NxStage Medical, Inc.
- CIK
- 1333170
- Industry
- Electromedical & Electrotherapeutic Apparatus
- Based in
- Lawrence, Massachusetts
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- SEC filer category
- Large accelerated filer
- Employer ID (EIN)
- 04-3454702
Key figures
| Fiscal year to | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 |
|---|---|---|---|---|---|
| Revenue | – | – | – | $301.5M | $263.4M |
| Operating income | −$13.9M | −$4.29M | −$14.6M | −$22.2M | −$17.8M |
| Net income | −$14.0M | −$4.77M | −$15.3M | −$23.9M | −$18.6M |
| Diluted EPS | −$0.22 | −$0.07 | −$0.24 | −$0.39 | −$0.31 |
| Cash from operations | $4.80M | $4.59M | $10.5M | −$20.3M | −$10.1M |
| Total assets | $325.6M | $317.2M | $306.9M | $309.7M | $307.0M |
| Shareholders’ equity | $213.2M | $201.4M | $191.8M | $190.5M | $194.2M |
From the company’s annual reports to the SEC. Each year links to its report.
Financials 58
- 10-Q Quarterly Report for period ending Sep 30, 2018
- 10-Q Quarterly Report for period ending Jun 30, 2018
- 10-Q Quarterly Report for period ending Mar 31, 2018
- 10-K Annual Report for period ending Dec 31, 2017
- 10-Q Quarterly Report for period ending Sep 30, 2017
- 10-Q Quarterly Report for period ending Jun 30, 2017
- 10-Q Quarterly Report for period ending Mar 31, 2017
- 10-K Annual Report for period ending Dec 31, 2016
- 10-Q Quarterly Report for period ending Sep 30, 2016
- 10-Q Quarterly Report for period ending Jun 30, 2016
News 126
- 8-K Material agreement ended; Acquisition or sale completed; Delisting notice; Change to shareholder rights; Change in control; Director or officer change; Charter or bylaw change
- 8-K Material agreement
- 8-K Material agreement
- 8-K Material agreement
- 8-K Other events
- 8-K Shareholder vote results
- 8-K Shareholder vote results
- 8-K Other events
- 8-K Shareholder vote results
- 8-K Material agreement; Financial results; Director or officer change; Charter or bylaw change; Regulation FD disclosure
Ownership 1,134
- SC 13G/A Major shareholder report (passive investor)
- 4 Change in insider ownership
- 4 Change in insider ownership
- 4 Change in insider ownership
- 4 Change in insider ownership
- 4 Change in insider ownership
- 4 Change in insider ownership
- 4 Change in insider ownership
- 4 Change in insider ownership
- 4 Change in insider ownership
Prospectus 49
- S-8 POS Post-effective amendment to a S-8 registration statement
- S-8 POS Post-effective amendment to a S-8 registration statement
- S-8 POS Post-effective amendment to a S-8 registration statement
- S-8 POS Post-effective amendment to a S-8 registration statement
- S-8 POS Post-effective amendment to a S-8 registration statement
- S-8 POS Post-effective amendment to a S-8 registration statement
- S-8 POS Post-effective amendment to a S-8 registration statement
- S-8 POS Post-effective amendment to a S-8 registration statement
- S-8 POS Post-effective amendment to a S-8 registration statement
- S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Proxies 26
- DEF 14A Definitive proxy statements
- DEFM14A Definitive proxy statement relating to a merger, acquisition, or disposition
- PREM14A Preliminary proxy statement relating to a merger, acquisition, or disposition
- DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
- DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
- DEF 14A Definitive proxy statements
- PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
- DEF 14A Definitive proxy statements
- DEF 14A Definitive proxy statements
- DEF 14A Definitive proxy statements
Other 92
- CT ORDER Order Granting Confidential Treatment
- CT ORDER Order Granting Confidential Treatment
- CT ORDER Order Granting Confidential Treatment
- CT ORDER Order Granting Confidential Treatment
- CT ORDER Order Granting Confidential Treatment
- CT ORDER Order Granting Confidential Treatment
- CT ORDER Order Granting Confidential Treatment
- 15-12G Notice of termination of registration of a class of securities under Section 12(g)
- 25-NSE Removal from exchange listing
- CT ORDER Order Granting Confidential Treatment